Alcohol use is common among people at risk for and aging with, HIV infection and plays a central modifiable role in their health outcomes. The goal of the CHAART Scientific Meeting is to foster interdisciplinary, cross consortia research collaboration and training focused on mitigating harmful health effects of alcohol among those with HIV infection including HIV transmission. Activities will be jointly led by consortia members and NIAAA scientific and program staff consistent with the cooperative agreement structure and act as an effective platform for discussion of both current and future research activities as a group.
The specific aims of the meeting include: 1. Update consortia members and key NIAAA and other NIH collaborators on recent findings 2. Enhance cross consortia data harmonization, problem solving, collaboration, and training 3. Provide strategic discussion of future research directions for each consortium 4. Provide a platform for discussion of integrative and collaborative activities
The purpose of the proposed meetings is to allow for cross-study collaboration amongst the various CHAART consortia. These meetings will provide the opportunity for interaction between investigators and National Institutes of Health staff where ideas and information can be shared in order to propel the quality of research produced by the various contributing groups.
|Althoff, Keri N; McGinnis, Kathleen A; Wyatt, Christina M et al. (2015) Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis 60:627-38|
|Gaither, Julie R; Goulet, Joseph L; Becker, William C et al. (2014) Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans. J Pain 15:1130-40|
|AkgÃ¼n, Kathleen M; Tate, Janet P; Crothers, Kristina et al. (2014) An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr 67:397-404|